CRISPR/Cas9 and related protein:RNA complexes are Gene Editing enzymes that are revolutionizing biological research and also starting to enter the therapeutic realm. A Cas9-based therapeutic strategy to treat sickle cell anemia received approval recently in the United Kingdom and is also being considered for FDA approval in the United States.
In this presentation, I will give a broad introduction to enzymes used for Gene Editing, including Cas9, base editors, and prime editors. This introduction is intended for both non-biologists and biologists, including the role of computational analysis in understanding gene editing outcomes.
Speaker(s): Dr. Pattanayak,
Virtual: https://events.vtools.ieee.org/m/386042
This event has passed.
